Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Kyverna Therapeutics, Inc. (KYTX) had Return on Equity of -23.15% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-38.32M |
|
-- |
|
-- |
|
$39.56M |
|
$-39.56M |
|
$1.24M |
|
$-38.32M |
|
$-38.32M |
|
$-38.32M |
|
$-38.32M |
|
$-38.32M |
|
$-38.32M |
|
$-39.56M |
|
$-39.12M |
|
60.90M |
|
60.90M |
|
$-0.63 |
|
$-0.63 |
|
| Balance Sheet Financials | |
$206.54M |
|
$1.33M |
|
$13.28M |
|
$219.82M |
|
$22.80M |
|
$24.88M |
|
$31.47M |
|
$54.27M |
|
$165.55M |
|
$165.55M |
|
$165.55M |
|
61.57M |
|
| Cash Flow Statement Financials | |
$-81.90M |
|
$-14.07M |
|
$3.69M |
|
$124.64M |
|
$32.36M |
|
$-92.29M |
|
$6.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.06 |
|
-- |
|
-- |
|
0.13 |
|
0.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-82.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-23.15% |
-23.15% |
|
-17.43% |
|
-20.12% |
|
$2.69 |
|
$-1.35 |
|
$-1.34 |
|